RxDoctor Payments Data

Nayantara Coelho-Prabhu, MD

Gastroenterology · Rochester, MNNPI 1831300128

Payments from drug & device makers

$37,498in general payments, 2019–2025

Across 73 payments — averaging $513.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$22K
  • Astrazeneca UK Limited$6K
  • AstraZeneca$5K
  • Olympus Corporation Of The Americas$3K
  • Creo Medical Inc.$1K
  • Iterative Scopes, Inc.$625
  • plus $443 from 3 others

What the payments were for

  • Consulting fees$10,96529%
  • Speaking & faculty fees$18,00048%
  • Travel & lodging$5,95916%
  • Food & beverage$2,5747%

General payments by program year

19
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific38$21,895
Astrazeneca UK Limited1$5,800
AstraZeneca1$4,640
Olympus Corporation Of The Americas21$2,804
Creo Medical Inc.5$1,291
Iterative Scopes, Inc.3$625
Olympus America Inc.2$212
Medtronic1$197
Micro-tech Endoscopy USA, Inc.1$34

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,498 in reported general payments places this provider in the 80th percentile of 365 gastroenterology providers in Minnesota.

See all gastroenterology providers in Minnesota

Medicare billing

Part B allowed, 2024
$55,943
Medicare patients
281
Services billed
409

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mesalamine17$5,941

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →